 |
|
|
|
PROCYTE TO REPORT SECOND QUARTER 2004 FINANCIAL RESULTS
ON THURSDAY, AUGUST 5, 2004
Redmond, Wash.—July 13, 2004—ProCyte Corporation (OTCBB: PRCY.OB)
a company that develops and markets skin care and procedure related products for the
dermatology, cosmetic surgery and spa markets based on its patented GHK
Copper Peptide Complex® technologies,
is scheduled to report financial results for the second quarter 2004 on
Thursday, August 5 before the market opens.
ProCyte will hold
a conference call at 4:00 p.m. EDT on Thursday, August 5, 2004 to
discuss its financial results and continuing business plans. Interested
parties are invited to listen to the call live by dialing 800-261-2045,
Passcode 64909#. For those parties unable to join the call, a replay
will be available until midnight Sunday, August 8, 2004 by calling
800-294-1193 and asking for the ProCyte playback.
ProCyte Corporation
develops and markets products based on its patented, clinically proven
Copper Peptide technology for skin health, hair care and wound care. The
Company sells directly to dermatologists, plastic and cosmetic surgeons,
spas and salons and through licenses with strategic partners into the
consumer market, including its long-term worldwide license agreement
with Neutrogena®, a Johnson & Johnson company. ProCyte brands
include Neova®,
VitalCopper™,
Simple Solutions® and AquaSanté®
Skin Care products; Complex Cu3®
Post-Procedure Skin Care; GraftCyte®
Hair Transplant Care; and Tricomin®
Advanced Care for Thinning Hair. The Company also has the exclusive
distribution rights for Cutanix Corporation’s Quadrinone®
technology in the U.S., Canada and Puerto Rico. Additional information
is available by visiting the Company’s website at www.procyte.com.
###
This release may contain forward-looking statements relating to the
research, development, commercialization, production, marketing and
distribution of the Company's products and future operating results,
which are subject to certain risks and uncertainties that could cause
actual results to differ materially from those projected.
The words “believe,”
“expect,” “intend,” “anticipate,” variations of such words, and similar
expressions identify forward-looking
statements, but their absence does not mean that the statement is not
forward-looking. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and
assumptions that are difficult to predict. Factors that could affect the
Company’s actual results include its ability to develop, commercialize
and produce new products; the market acceptance of existing and
potential future products; the availability, cost and timely delivery of
materials and services from and performance of third-party suppliers,
manufacturers, distributors, licensees and other collaborative partners;
the satisfaction of regulatory requirements, and the receipt, timing,
terms and conditions of required regulatory approvals. Reference is
made to the Company’s Annual Report on Form 10-K for the year ended
December 31, 2003 and its latest quarterly report on Form 10Q filed with
the Securities and Exchange Commission for a more detailed description
of such factors. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date of
this release. The Company undertakes no obligation to publicly update
any forward-looking statement to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events. |
|
|
|
